Hot News
UK becomes first country to approve Merck’s COVID-19 pill
The first at-home pill to treat COVID-19 has been approved by Britain’s medicines watchdog.
Antiviral molnupiravir was shown in clinical trials to slash the risk of hospitalisation by half in vulnerable and elderly patients.
The tablet, which will be sold under the brand name Lagevrio, will be given twice a day to people within a week of testing positive.
It will be targeted at those who are considered high risk, including Britons over the age of 60, or patients with heart disease, diabetes, obesity, or other comorbidities.
Health secretary Sajid Javid said the treatment was a ‘gamechanger’ for the most frail and immunosuppressed, who are vulnerable to Covid even when vaccinated.
The UK has bought 480,000 doses of molnupiravir at a cost thought to be in the region of £250million.
Announcing its approval today, the UK’s Medicines and Healthcare products Regulatory Agency said the drug was safe and effective
Molnupiravir, made by pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics, works by blocking the virus from replicating in the body.
The MHRA said the drug should be taken as soon as possible following a positive Covid test and within the first five days.
-
Crime23 hours ago
Police bust PoS scam syndicate, arrest four suspects in Katsina
-
Entertainment21 hours ago
Fireboy covers Styl Plus’ ‘Olufunmi’, sparks debate
-
News11 hours ago
Kidnapped victim sues bus company for negligence, demands N13m
-
News11 hours ago
Lagos court remands 22-year-old for stealing TV sets
-
Metro11 hours ago
Ondo NSCDC parade three suspects involved in criminal activity
-
Politics10 hours ago
Kano gov orders arrest of deposed Emir Bayero
-
Economy10 hours ago
FCTA plans to open Abuja business school
-
News11 hours ago
UK-based Nigerian-born woman becomes first African Lord Mayor of Leeds